• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

垂体手术后促甲状腺激素异常。

Abnormal thyroid stimulating hormone following pituitary surgery.

作者信息

Worth G K, Retallack R W, Gutteridge D H

出版信息

J Endocrinol Invest. 1981 Apr-Jun;4(2):233-6. doi: 10.1007/BF03350459.

DOI:10.1007/BF03350459
PMID:7276463
Abstract

Biologically inactive thyroid stimulating hormone (TSH) has been reported in hypothyroid patients. We report the first case of immunoreactive, but abnormal TSH in a euthyroid patient following hypophysectomy for a prolactin secreting pituitary adenoma. Indirect evidence indicates that this abnormal TSH was biologically inactive. The TSH was characterized by gel chromatography and has a molecular weight of approximately 23,000 daltons.

摘要

甲状腺功能减退患者中曾有生物学无活性的促甲状腺激素(TSH)的报道。我们报告了第一例在因分泌催乳素的垂体腺瘤行垂体切除术后甲状腺功能正常的患者中出现免疫反应性但异常的TSH的病例。间接证据表明这种异常的TSH在生物学上无活性。通过凝胶色谱法对该TSH进行了表征,其分子量约为23,000道尔顿。

相似文献

1
Abnormal thyroid stimulating hormone following pituitary surgery.垂体手术后促甲状腺激素异常。
J Endocrinol Invest. 1981 Apr-Jun;4(2):233-6. doi: 10.1007/BF03350459.
2
A human pituitary adenoma secreting thyrotropin and prolactin: immunohistochemical, biochemical, and cell culture studies.一例分泌促甲状腺激素和催乳素的人垂体腺瘤:免疫组织化学、生物化学及细胞培养研究
J Clin Endocrinol Metab. 1984 Nov;59(5):817-24. doi: 10.1210/jcem-59-5-817.
3
Normal pituitary function and reserve after selective transsphenoidal removal of a thyrotropin-producing pituitary adenoma.
Metabolism. 1980 Aug;29(8):739-44. doi: 10.1016/0026-0495(80)90196-1.
4
The pituitary-thyroid axis in patients with pituitary disorders.
Horm Metab Res. 1989 Jul;21(7):387-90. doi: 10.1055/s-2007-1009244.
5
[Acute pituitary failure as the presentation of a prolactin cell adenoma during a pregnancy made possible by bromocriptine (author's transl)].溴隐亭使妊娠成为可能期间,以急性垂体功能衰竭为表现的催乳素细胞腺瘤(作者译)
Nouv Presse Med. 1977 Nov 12;6(38):3525-L, 3531.
6
Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.促甲状腺激素分泌型垂体腺瘤的临床病理特征及治疗结果:一项90例的单中心研究
J Neurosurg. 2014 Dec;121(6):1462-73. doi: 10.3171/2014.7.JNS1471. Epub 2014 Sep 19.
7
Thyroid-stimulating hormone, prolactin, and growth hormone response to thyrotropin-releasing hormone in treated children with congenital hypothyroidism.先天性甲状腺功能减退症患儿经治疗后促甲状腺激素、催乳素及生长激素对促甲状腺激素释放激素的反应。
Pediatr Res. 1985 Oct;19(10):1037-9. doi: 10.1203/00006450-198510000-00018.
8
Prolactin secretion after surgery or bromocriptine treatment of prolactinoma.泌乳素瘤手术后或使用溴隐亭治疗后的泌乳素分泌。
Obstet Gynecol. 1987 Jan;69(1):99-103.
9
A case of thyrotropin (TSH)-secreting tumor complicated by periodic paralysis.一例促甲状腺激素(TSH)分泌瘤合并周期性麻痹。
Jpn J Med. 1990 Jul-Aug;29(4):399-404. doi: 10.2169/internalmedicine1962.29.399.
10
Thyroid-stimulating hormone pituitary adenomas.促甲状腺激素垂体腺瘤
J Neurosurg. 2008 Jul;109(1):17-22. doi: 10.3171/JNS/2008/109/7/0017.

引用本文的文献

1
Radioligand receptor assay for TSH and TSH-binding-inhibiting antibodies using solubilized TSH-receptor.使用可溶性促甲状腺激素受体的促甲状腺激素及促甲状腺激素结合抑制性抗体的放射性配体受体分析
J Endocrinol Invest. 1983 Apr;6(2):135-8. doi: 10.1007/BF03350586.

本文引用的文献

1
Measurements of the thyroid-stimulating hormone content of serum from hypothyroid and euthyroid people.
J Clin Endocrinol Metab. 1968 Mar;28(3):325-31. doi: 10.1210/jcem-28-3-325.
2
Human and porcine thyrotropins: a comparison of electrophoretic and immunological properties with the bovine hormone.
Arch Biochem Biophys. 1968 Aug;126(2):444-55. doi: 10.1016/0003-9861(68)90429-3.
3
Inhibition of thyrotropin and prolactin secretions in primary hypothyroidism by 2-Br-alpha-ergocryptine.
J Clin Endocrinol Metab. 1974 Aug;39(2):391-4. doi: 10.1210/jcem-39-2-391.
4
Glandular end organ deficiency associated with secretion of biologically inactive pituitary peptides.与生物活性垂体肽分泌相关的腺性终末器官缺乏症。
J Clin Endocrinol Metab. 1974 Jun;38(6):964-75. doi: 10.1210/jcem-38-6-964.
5
Serum thyrotropin (TSH) in pituitary and-or hypothalamic hypothyroidism: normal or elevated basal levels and paradoxical responses to thyrotropin-releasing hormone.垂体性和/或下丘脑性甲状腺功能减退症中的血清促甲状腺激素(TSH):基础水平正常或升高以及对促甲状腺激素释放激素的反常反应。
J Clin Endocrinol Metab. 1973 Aug;37(2):190-6. doi: 10.1210/jcem-37-2-190.
6
Chromatographic differences between circulating and pituitary thyrotropins.
J Clin Endocrinol Metab. 1974 Aug;39(2):316-25. doi: 10.1210/jcem-39-2-316.
7
Hyperthyroidism and excessive thyrotropin secretion.甲状腺功能亢进与促甲状腺素分泌过多。
N Engl J Med. 1972 Aug 17;287(7):328-33. doi: 10.1056/NEJM197208172870704.
8
Case of hyperthyroidism due to a chromophobe adenoma.嫌色性腺瘤所致甲状腺功能亢进病例。
Clin Endocrinol (Oxf). 1976 Mar;5(2):145-50. doi: 10.1111/j.1365-2265.1976.tb02825.x.
9
Recurrent goiter, hyperthyroidism, galactorrhea and amenorrhea due to a thyrotropin and prolactin-producing pituitary tumor.由分泌促甲状腺激素和催乳素的垂体肿瘤引起的复发性甲状腺肿、甲状腺功能亢进、溢乳和闭经。
J Clin Endocrinol Metab. 1976 Jul;43(1):137-43. doi: 10.1210/jcem-43-1-137.
10
The secretion of thyrotrophin with impaired biological activity in patients with hypothalamic-pituitary disease.
Clin Endocrinol (Oxf). 1978 May;8(5):397-402. doi: 10.1111/j.1365-2265.1978.tb02174.x.